Ozempic Triples Stomach Paralysis Risks Among Users With millions of Americans opting for injectable weight management medications like Ozempic and Wegovy, a study published in the Journal of the American Medical Association (JAMA) on October 5, 2023, revealed that Ozempic users are three times more likely to experience stomach paralysis than individuals using alternative oral weight loss medications
Water retention from sodium intake, hormonal cycles, exercise-induced inflammation, or even stress can mask ongoing fat loss
Use is not recommended while breastfeeding
On the flip side, use of GLP-1s could potentially decrease the risk of serious cardiac events like heart attack
This synthetic version of the naturally occurring GLP-1 hormone which binds to GLP-1 receptors in the body, enhancing insulin secretion when blood sugar levels are high and reducing the livers glucose production
This drives the need for a gradual dose increase, as described below